In an Aβ-induced AD model, treatment with Cycloastragenol resulted in elevated levels of Nrf2 and HO-1 and a decrease in levels of ROS and lipid peroxidation (LPO) in the mouse brain, highlighting its potent antioxidant activity [169]. The gene discussed is HMOX1; the disease is Alzheimer disease.